The Pharmaceutical Quality System (ICH Q10)
ICH Q10 describes a comprehensive model for an effective pharmaceutical quality system (PQS) across the entire product lifecycle, built on ISO quality-management concepts, GMP, and ICH Q8 and Q9. It is the system that holds every other discipline together — the thing an inspector means when they refer to "your quality system".
One system, the whole lifecycle
The defining idea of ICH Q10 is lifecycle scope. The same quality system spans pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation — so knowledge and control carry forward rather than being rebuilt at each stage. A quality system that only wakes up at commercial manufacturing has already lost the development knowledge that makes control possible.
The four elements
Q10 names four elements that operate across the lifecycle: a process performance and product quality monitoring system; a corrective action and preventive action (CAPA) system; a change management system; and management review of process performance and product quality. These are the machinery of a working PQS — the parts that turn "we have procedures" into "we are demonstrably in control".
Crucially they interlock: monitoring surfaces signals, CAPA acts on them, change management implements the fix under control, and management review governs the whole loop. A gap in any one weakens the others.
The two enablers — knowledge management and QRM
Two enablers run underneath everything: knowledge management (capturing and using product and process knowledge across the lifecycle) and quality risk management (ICH Q9). They are what make the four elements intelligent rather than mechanical — risk decides where to focus, and knowledge makes each decision better than the last.
Management responsibility
ICH Q10 places senior management explicitly on the hook: for the quality policy, for resources, for the quality system’s design and effectiveness, and for management review. This is the same leadership-ownership theme FDA’s Quality Management Maturity program frames as Management Commitment — a PQS is only as real as the leadership behind it.
PQS and ISO 9001
ICH Q10 is built on ISO 9001 quality-management principles but is pharma-specific and GMP-anchored — it augments GMP rather than replacing it, and it reaches into development where GMP does not. A firm can hold ISO 9001 certification and still need a Q10-compliant PQS; the two are complementary, not interchangeable.
Derived from the 4 standards that anchor this topic.
What is ICH Q10?
ICH Q10 is the international guideline describing a model for an effective Pharmaceutical Quality System across the product lifecycle — development, technology transfer, commercial manufacturing, and discontinuation. It is built on ISO concepts and complements GMP and ICH Q8/Q9.
What are the four elements of the PQS?
A process performance and product quality monitoring system; a CAPA system; a change management system; and management review of process performance and product quality — the four interlocking systems that operate across the lifecycle.
What are the two PQS enablers?
Knowledge management and quality risk management (ICH Q9). They run underneath the four elements — risk directs effort, and knowledge carried across the lifecycle makes each quality decision better than the last.
How does ICH Q10 relate to ISO 9001?
ICH Q10 is founded on ISO 9001 quality-management principles but is pharmaceutical-specific and anchored to GMP, extending into development. Holding ISO 9001 does not by itself satisfy Q10; the two are complementary.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.